| 1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1):1-6.
|
| 2 |
Strassen U, Hofauer B, Matsuba Y, et al. Bronchogenic cancer: It still exists[J]. Laryngoscope, 2016, 126(3):638-642.
|
| 3 |
Bednarek AK, Keck-Waggoner CL, Daniel RL, et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth[J]. Cancer Res, 2001, 61(22):8068-8073.
|
| 4 |
Mahajan NP, Whang YE, Mohler JL, et al. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox[J]. Cancer Res, 2005, 65(22):10514-10523.
|
| 5 |
Chang NS, Pratt N, Heath J, et al. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity[J]. J Biol Chem, 2001, 276(5):3361-3370.
|
| 6 |
Kremer EJ, Pritchard M, Lynch M, et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n[J]. Science, 1991, 252(5013):1711-1714.
|
| 7 |
Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis[J]. Nature, 2005, 436(7051):725-730.
|
| 8 |
Heavey S, O′Byrne KJ, Gately K. Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC[J]. Cancer Treat Rev, 2014, 40(3):445-456.
|
| 9 |
Printz C. Lung cancer new leading cause of death for women in developed countries: Data reflects increased rates of smoking[J]. Cancer, 2015, 121(12):1911-1912.
|
| 10 |
Schrock MS, Huebner K. WWOX: a fragile tumor suppressor[J]. Exp Biol Med (Maywood), 2015, 240(3):296-304.
|
| 11 |
Puciennik E, Nowakowska M, Stpien A, et al. Alternating expression levels of WWOX tumor suppressor and cancer-related genes in patients with bladder cancer[J]. Oncol Lett, 2014, 8(5):2291-2297.
|
| 12 |
Huang YC, Hung WC, Chen WT, et al. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells[J]. Toxicol Lett, 2013, 220(2):118-125.
|
| 13 |
Del MS, Husanie H, Iancu O, et al. WWOX and p53 dysregulation synergize to drive the development of osteosarcoma[J]. Cancer Res, 2016, 76(20):6107-6117.
|
| 14 |
Nowakowska M, Puciennik E, Wujcicka WI, et al. The correlation analysis of WWOX expression and cancer related genes in neuroblastoma-a real time RT-PCR study[J]. Acta Biochim Pol, 2014, 61(1):91-97.
|
| 15 |
Nowakowska M, Pospiech K, Lewandowska U, et al. Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines[J]. Tumour Biol, 2014, 35(9):9291-9301.
|
| 16 |
Guler G, Uner A, Guler N, et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma[J]. Cancer, 2004, 100(8):1605-1614.
|
| 17 |
Lin JT, Li HY, Chang NS, et al. WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase[J]. Cell Cycle, 2015, 14(3):408-416.
|
| 18 |
Li G, Sun L, Mu Z, et al. Ectopic WWOX expression inhibits growth of 5 637 bladder cancer cell in vitro and in vivo[J]. Cell Biochem Biophys, 2015, 73(2):417-425.
|
| 19 |
Ekizoglu S, Bulut P, Karaman E, et al. Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma[J]. PLoS One, 2015, 10(1):e0115353.
|
| 20 |
Dahia PL. PTEN, a unique tumor suppressor gene[J]. Endocr Relat Cancer, 2000, 7(2):115-129.
|
| 21 |
Carnero A, Blanco-Aparicio C, Renner O, et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications[J]. Curr Cancer Drug Targets, 2008, 8(3):187-198.
|
| 22 |
Sushma PS, Jamil K, Kumar PU, et al. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population[J]. Tumour Biol, 2016, 37(6):7625-7632.
|
| 23 |
Xiao WZ, Han DH, Wang F, et al. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis[J]. Tumour Biol, 2014, 35(7):6687-6693.
|
| 24 |
Zhang X, Park JS, Park KH, et al. PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer[J]. Oncology, 2015, 88(2):76-85.
|